Literature DB >> 14728237

Adequacy of representation of the National Drug File Reference Terminology Physiologic Effects reference hierarchy for commonly prescribed medications.

S Trent Rosenbloom1, Joseph Awad, Ted Speroff, Peter L Elkin, Russell Rothman, Anderson Spickard, Josh Peterson, Brent A Bauer, Dietland L Wahner-Roedler, Mark Lee, William M Gregg, Kevin B Johnson, Jim Jirjis, Mark S Erlbaum, John S Carter, Michael J Lincoln, Steven H Brown.   

Abstract

The National Drug File Reference Terminology contains a novel reference hierarchy to describe physiologic effects (PE) of drugs. The PE reference hierarchy contains 1697 concepts arranged into two broad categories; organ specific and generalized systemic effects. This investigation evaluated the appropriateness of the PE concepts for classifying a random selection of commonly prescribed medications. Ten physician reviewers classified the physiologic effects of ten drugs and rated the accuracy of the selected term. Inter reviewer agreement, overall confidence, and concept frequencies were assessed and were correlated with the complexity of the drug's known physiologic effects. In general, agreement between reviewers was fair to moderate (kappa 0.08-0.49). The physiologic effects modeled became more disperse with drugs having and inducing multiple physiologic processes. Complete modeling of all physiologic effects was limited by reviewers focusing on different physiologic processes. The reviewers were generally comfortable with the accuracy of the concepts selected. Overall, the PE reference hierarchy was useful for physician reviewers classifying the physiologic effects of drugs. Ongoing evolution of the PE reference hierarchy as it evolves should take into account the experiences of our reviewers.

Mesh:

Substances:

Year:  2003        PMID: 14728237      PMCID: PMC1480331     

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN: 1559-4076


  9 in total

1.  Clinical classification and terminology: some history and current observations.

Authors:  C G Chute
Journal:  J Am Med Inform Assoc       Date:  2000 May-Jun       Impact factor: 4.497

2.  PharmGKB: the Pharmacogenetics Knowledge Base.

Authors:  Micheal Hewett; Diane E Oliver; Daniel L Rubin; Katrina L Easton; Joshua M Stuart; Russ B Altman; Teri E Klein
Journal:  Nucleic Acids Res       Date:  2002-01-01       Impact factor: 16.971

3.  Ontology development for a pharmacogenetics knowledge base.

Authors:  Diane E Oliver; Daniel L Rubin; Joshua M Stuart; Micheal Hewett; Teri E Klein; Russ B Altman
Journal:  Pac Symp Biocomput       Date:  2002

4.  Guideline and quality indicators for development, purchase and use of controlled health vocabularies.

Authors:  Peter L Elkin; Steven H Brown; John Carter; Brent A Bauer; Dietlind Wahner-Roedler; Larry Bergstrom; Mark Pittelkow; Cornelius Rosse
Journal:  Int J Med Inform       Date:  2002-12-18       Impact factor: 4.046

5.  A semantic normal form for clinical drugs in the UMLS: early experiences with the VANDF.

Authors:  Stuart J Nelson; Steven H Brown; Mark S Erlbaum; Nels Olson; Tammy Powell; Brian Carlsen; John Carter; Mark S Tuttle; William T Hole
Journal:  Proc AMIA Symp       Date:  2002

6.  Initializing the VA medication reference terminology using UMLS metathesaurus co-occurrences.

Authors:  John S Carter; Steven H Brown; Mark S Erlbaum; William Gregg; Peter L Elkin; Ted Speroff; Mark S Tuttle
Journal:  Proc AMIA Symp       Date:  2002

7.  The genomic revolution and medicine.

Authors:  Richard M Weinshilboum
Journal:  Mayo Clin Proc       Date:  2002-08       Impact factor: 7.616

8.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

9.  A framework for comprehensive health terminology systems in the United States: development guidelines, criteria for selection, and public policy implications. ANSI Healthcare Informatics Standards Board Vocabulary Working Group and the Computer-Based Patient Records Institute Working Group on Codes and Structures.

Authors:  C G Chute; S P Cohn; J R Campbell
Journal:  J Am Med Inform Assoc       Date:  1998 Nov-Dec       Impact factor: 4.497

  9 in total
  8 in total

1.  Analyzing categorical information in two publicly available drug terminologies: RxNorm and NDF-RT.

Authors:  Jyotishman Pathak; Christopher G Chute
Journal:  J Am Med Inform Assoc       Date:  2010 Jul-Aug       Impact factor: 4.497

Review 2.  Interface terminologies: facilitating direct entry of clinical data into electronic health record systems.

Authors:  S Trent Rosenbloom; Randolph A Miller; Kevin B Johnson; Peter L Elkin; Steven H Brown
Journal:  J Am Med Inform Assoc       Date:  2006-02-24       Impact factor: 4.497

3.  ADESSA: A Real-Time Decision Support Service for Delivery of Semantically Coded Adverse Drug Event Data.

Authors:  Jon D Duke; Jeff Friedlin
Journal:  AMIA Annu Symp Proc       Date:  2010-11-13

4.  Extracting drug indication information from structured product labels using natural language processing.

Authors:  Kin Wah Fung; Chiang S Jao; Dina Demner-Fushman
Journal:  J Am Med Inform Assoc       Date:  2013-03-09       Impact factor: 4.497

5.  Drug-drug Interaction Discovery Using Abstraction Networks for "National Drug File - Reference Terminology" Chemical Ingredients.

Authors:  Christopher Ochs; Ling Zheng; Huanying Gu; Yehoshua Perl; James Geller; Joan Kapusnik-Uner; Aleksandr Zakharchenko
Journal:  AMIA Annu Symp Proc       Date:  2015-11-05

6.  Quality assurance of chemical ingredient classification for the National Drug File - Reference Terminology.

Authors:  Ling Zheng; Hasan Yumak; Ling Chen; Christopher Ochs; James Geller; Joan Kapusnik-Uner; Yehoshua Perl
Journal:  J Biomed Inform       Date:  2017-07-16       Impact factor: 6.317

7.  A model for evaluating interface terminologies.

Authors:  S Trent Rosenbloom; Randolph A Miller; Kevin B Johnson; Peter L Elkin; Steven H Brown
Journal:  J Am Med Inform Assoc       Date:  2007-10-18       Impact factor: 4.497

8.  Standardizing adverse drug event reporting data.

Authors:  Liwei Wang; Guoqian Jiang; Dingcheng Li; Hongfang Liu
Journal:  J Biomed Semantics       Date:  2014-08-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.